TNFSF13
From Wikipedia, the free encyclopedia
|
Tumor necrosis factor (ligand) superfamily, member 13
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | TNFSF13; APRIL; CD256; TALL2; TRDL-1; UNQ383/PRO715; ligand | |||||||||||||
| External IDs | OMIM: 604472 MGI: 1916833 HomoloGene: 56971 | |||||||||||||
|
||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 8741 | 69583
|
||||||||||||
| Refseq | NM_003808 (mRNA) NP_003799 (protein) |
NM_023517 (mRNA) NP_076006 (protein) |
||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Tumor necrosis factor (ligand) superfamily, member 13, also known as TNFSF13, is a human gene.[1] TNFSF13 has also been designated CD256 (cluster of differentiation 256).
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.[1]
[edit] References
[edit] Further reading
- Bossen C, Schneider P (2007). "BAFF, APRIL and their receptors: structure, function and signaling.". Semin. Immunol. 18 (5): 263–75. doi:. PMID 16914324.
- Tangye SG, Bryant VL, Cuss AK, Good KL (2007). "BAFF, APRIL and human B cell disorders.". Semin. Immunol. 18 (5): 305–17. doi:. PMID 16916610.
- Treml LS, Crowley JE, Cancro MP (2007). "BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.". Semin. Immunol. 18 (5): 297–304. doi:. PMID 16919470.
- Mackay F, Leung H (2007). "The role of the BAFF/APRIL system on T cell function.". Semin. Immunol. 18 (5): 284–9. doi:. PMID 16931039.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149.
- Hahne M, Kataoka T, Schröter M, et al. (1998). "APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.". J. Exp. Med. 188 (6): 1185–90. PMID 9743536.
- Shu HB, Hu WH, Johnson H (1999). "TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.". J. Leukoc. Biol. 65 (5): 680–3. PMID 10331498.
- Cousin P, Billotte J, Chaubert P, Shaw P (2000). "Physical map of 17p13 and the genes adjacent to p53.". Genomics 63 (1): 60–8. doi:. PMID 10662545.
- Kelly K, Manos E, Jensen G, et al. (2000). "APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death.". Cancer Res. 60 (4): 1021–7. PMID 10706119.
- Wu Y, Bressette D, Carrell JA, et al. (2001). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.". J. Biol. Chem. 275 (45): 35478–85. doi:. PMID 10956646.
- Yu G, Boone T, Delaney J, et al. (2001). "APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.". Nat. Immunol. 1 (3): 252–6. doi:. PMID 10973284.
- Gallouzi IE, Brennan CM, Steitz JA (2001). "Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.". RNA 7 (9): 1348–61. PMID 11565755.
- López-Fraga M, Fernández R, Albar JP, Hahne M (2002). "Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase.". EMBO Rep. 2 (10): 945–51. doi:. PMID 11571266.
- Stein JV, López-Fraga M, Elustondo FA, et al. (2002). "APRIL modulates B and T cell immunity.". J. Clin. Invest. 109 (12): 1587–98. PMID 12070306.
- Litinskiy MB, Nardelli B, Hilbert DM, et al. (2002). "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.". Nat. Immunol. 3 (9): 822–9. doi:. PMID 12154359.
- Roschke V, Sosnovtseva S, Ward CD, et al. (2002). "BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.". J. Immunol. 169 (8): 4314–21. PMID 12370363.
- Pradet-Balade B, Medema JP, López-Fraga M, et al. (2002). "An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.". EMBO J. 21 (21): 5711–20. PMID 12411489.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi:. PMID 12975309.
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.

